NCT04404959

Brief Summary

The objective of this trial will be to establish whether the ultrasound-guided suprainguinal fascia iliaca compartment block is capable of protecting geriatric patients with hip fracture from delirium as compared to placebo

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 10, 2019

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

May 22, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 28, 2020

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

July 12, 2022

Status Verified

July 1, 2022

Enrollment Period

4.6 years

First QC Date

May 22, 2020

Last Update Submit

July 10, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • pain score 30 minutes after fascia iliaca block

    pain score by the use of Numeric Rating Scale (NRS) 30 minutes after fascia ilaca block, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"

    30 minutes after performance of fascia iliaca block

  • pain score 12 hours after fascia iliaca block

    pain score by the use of Numeric Rating Scale (NRS) 12 hours after fascia ilaca block, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"

    12 hours after performance of fascia iliaca block

Secondary Outcomes (1)

  • pain score 1-8 days after fascia iliaca block

    1-8 days after fascia iliaca block

Other Outcomes (6)

  • Mini Mental State examination

    arrival to the emergency room

  • Mini Mental State examination

    1-8 days postoperatively

  • Confusion Assessment Method

    arrival to the emergency room

  • +3 more other outcomes

Study Arms (2)

fascia iliaca compartment block with ropivacaine

ACTIVE COMPARATOR

in this arm, the fascia iliaca compartment block will be performed with 40 mL ropivacaine 0.25%

Other: fascia iliaca compartment block with ropivacaine

fascia iliaca compartment block with placebo

PLACEBO COMPARATOR

in this arm, the fascia iliaca compartment block will be performed with 40 mL normal saline

Other: fascia iliaca compartment block with placebo

Interventions

the fascia iliaca compartment block catheter will be placed with the use of ultrasound till the day of surgery. Bolus doses will be given every 12 hours (40 ml of ropivacaine 0.25%)

Also known as: medication in regional anesthetic technique
fascia iliaca compartment block with ropivacaine

the fascia iliaca compartment block catheter will be placed with the use of ultrasound till the day of surgery. Bolus doses will be given every 12 hours (40 ml of normal saline)

Also known as: medication in regional anesthetic technique
fascia iliaca compartment block with placebo

Eligibility Criteria

Age75 Years - 105 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • geriatric patients
  • American Society of Anesthesiologists (ASA) I-III
  • hip fracture patients

You may not qualify if:

  • dementia
  • communication or language barriers
  • patients with nutritional problems
  • bedridden patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KAT General Hospital of Athens

Kifissia, 14561, Greece

RECRUITING

Related Publications (5)

  • Unneby A, Svensson PO, Gustafson PY, Lindgren APB, Bergstrom U, Olofsson PB. Complications with focus on delirium during hospital stay related to femoral nerve block compared to conventional pain management among patients with hip fracture - A randomised controlled trial. Injury. 2020 Jul;51(7):1634-1641. doi: 10.1016/j.injury.2020.04.013. Epub 2020 Apr 20.

    PMID: 32360090BACKGROUND
  • Zhao X, Yuan W. Perioperative Multicomponent Interdisciplinary Program Reduces Delirium Incidence in Elderly Patients With Hip Fracture. J Am Psychiatr Nurses Assoc. 2022 Mar;28(2):154-163. doi: 10.1177/1078390320915250. Epub 2020 Apr 13.

    PMID: 32281905BACKGROUND
  • Poeran J, Cozowicz C, Zubizarreta N, Weinstein SM, Deiner SG, Leipzig RM, Friedman JI, Liu J, Mazumdar M, Memtsoudis SG. Modifiable factors associated with postoperative delirium after hip fracture repair: An age-stratified retrospective cohort study. Eur J Anaesthesiol. 2020 Aug;37(8):649-658. doi: 10.1097/EJA.0000000000001197.

    PMID: 32251149BACKGROUND
  • Uysal AI, Altiparmak B, Yasar E, Turan M, Canbek U, Yilmaz N, Gumus Demirbilek S. The effects of early femoral nerve block intervention on preoperative pain management and incidence of postoperative delirium geriatric patients undergoing trochanteric femur fracture surgery: A randomized controlled trial. Ulus Travma Acil Cerrahi Derg. 2020 Jan;26(1):109-114. doi: 10.14744/tjtes.2019.78002.

    PMID: 31942744BACKGROUND
  • Scurrah A, Shiner CT, Stevens JA, Faux SG. Regional nerve blockade for early analgesic management of elderly patients with hip fracture - a narrative review. Anaesthesia. 2018 Jun;73(6):769-783. doi: 10.1111/anae.14178. Epub 2017 Dec 26.

    PMID: 29278266BACKGROUND

MeSH Terms

Conditions

DeliriumHip FracturesDementiaPainAgnosia

Interventions

RopivacaineDosage Forms

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersFemoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg InjuriesBrain DiseasesCentral Nervous System DiseasesPerceptual Disorders

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesPharmaceutical PreparationsTechnology, PharmaceuticalInvestigative Techniques

Study Officials

  • Kassiani Theodoraki, PhD, DESA

    Aretaieion University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kassiani Theodoraki, PhD, DESA

CONTACT

Krystallia Vitoula, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesiology

Study Record Dates

First Submitted

May 22, 2020

First Posted

May 28, 2020

Study Start

May 10, 2019

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

July 12, 2022

Record last verified: 2022-07

Locations